Edwards Lifesciences Breaks to a New 52-Week High at $95.20
As seen on the 24/7 Wall St. homepage on November 3, 2026.
Edwards Lifesciences cleared its July 6 ceiling by a hair at $95.20, a fresh 52-week high for the $54.8 billion heart valve maker. The stock has climbed back from $78 in February without a new peak until now.
Continue ReadingShow less
Edwards Lifesciences touched $95.20 on November 3, clearing the prior 52-week ceiling set on July 6. The clearance is thin, but a fresh peak tends to matter more to momentum investors than the size of the gap.
Shares fell to around $78 in February, so the stock clawed back a substantial stretch of lost ground to reach a level the market had not seen in over a year.
Sponsored
Repeated pushes above $91 since late spring have each found support at a higher floor, a structure that gives buyers confidence the trend has staying power.
For a company valued at $54.8 billion in the heart valve space, the focus now sits squarely on price action: whether $95.20 becomes a launching pad or a ceiling that reasserts itself on any near-term softness.
Sources
Mentioned: EW